More about New Malaria Vaccine

New Malaria Vaccine has been approved and recommended for used by the world health organization

Attention India
3 Min Read
More about New Malaria Vaccine

7th October 2023, Mumbai: Scientists of the Oxford University have studied and developed a new vaccine to prevent the disease like malaria.

What about the details about the vaccine

The Name of the vaccine is R21/Matrix-M, and has been developed to help prevent media. According to WHO, a condition that affected an estimated 247 million people in 2021. Here the report said, there are major cases of malaria. According to the World malaria report, 200 million cases worldwide with over 600,000 deaths and children suffered a lot under the age of 5. In accounting 75 % are deaths.

This is the second vaccine of malaria. The first name of the malaria vaccine is RTS,S/AS01 which will be recommended in 2021.

This vaccine is manufactured by Serum Institute of India,l. according to Reuters and they expected the cost of the vaccine was low so every patient can get a dose. new vaccine requires three doses with a booster 12 months.

How malaria was spread

Malaria is not like a Covid-19. It is not transmitted to other people but it is infected due to mosquitos.

As this infection is transmitted by mosquitoes, Dionne, said “the use of [insecticide-treated bed nets] in regions of the world with malaria has been proven to be highly effective to prevent bites” but availability can sometimes be a challenge.

How will it get access to the vaccine?

The Serum Institute of India, says that they have already established a production capacity to develop 100 million doses per year with further being able to create over 200 million doses per year in the next two years.

“These many available doses will help create and prevent illness for many more children in high transmission locations,” said Schaffner.

Schaffner explained public health officials will target populations most affected by malaria to help prevent severe disease and death.

“Children are more affected by malaria and the aim of these vaccines is toward that particularly vulnerable population,” explained Schaffner.

Share This Article
Leave a comment

Leave a Reply